Clinical Trial

A Trial of SHR-1139 in Healthy Volunteers

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess safety, PK and immunogenicity profile of a single dose of SHR-1139 in healthy volunteers
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-07-13; most recent amendment 2026-03-17.
Status change: Recruiting → Active, Not Recruiting 2026-02-18
Status change: Not Yet Recruiting → Recruiting 2025-09-07
Trial Details
NCT Number NCT07078695
Lead Sponsor Atridia Pty Ltd.
Conditions Psoriasis
Enrollment 24 participants
Start Date 2025-08-19
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-19